Hot Keywords
Rett Syndrome Intellectual disability mitochondrial disease next-generation sequencing language disorders monogenic epilepsies early-onset epilepsy movement disorders autism suicide schizophrenia

Topic: Genetics and Epigenetics of Neurodegenerative Diseases

A special issue of Journal of Translational Genetics and Genomics.

ISSN 2578-5281 (Online)

Submission deadline: 30 Jun 2021

Guest Editor(s)

  • Prof. Fabio Coppedè
    Department of Translational Research and of New Surgical and Medical Technologies, Medical Genetics Laboratory, University of Pisa, Pisa, Italy.

    Website | E-mail

Special Issue Introduction

Neurodegenerative diseases (NDD) are a heterogeneous group of conditions leading to gradual and progressive cognitive or movement impairments, depending on the type of neuronal cells undergoing selective degeneration with the diseases. They include Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis. All of them are characterized by a minority of monogenic forms and by the vast majority of the cases resulting from complex interactions between genetic and environmental factors, conditions such as Huntington’s disease or spinocerebellar ataxias that are completely hereditary, and prion diseases including inherited, sporadic and acquired forms. Together with the genetic factors contributing to neurodegeneration, increasing evidence points to a role for epigenetic modifications such as DNA methylation, histone tail modifications and non-coding RNA mediated mechanisms. This special issue aims to provide a detailed and updated overview on the genetics and epigenetics of NDD. Indeed, we expect to collect cutting-edge basic research articles aimed at identifying genetic and epigenetic biomarkers of these disorders, as well as updated narrative reviews on a given disease or a disease category. Genome-wide (GWAS) and epigenome-wide association studies (EWAS), and their systematic review and meta-analysis are particularly welcome. We are also interested in candidate-gene investigations, articles dealing with the application of the polygenic risk score in major NDD, and papers addressing the contribution of environmental factors to the epigenetic changes observed in these conditions. Papers focusing on the translation potential and the clinical utility of these biomarkers are also of interest.

Submission Deadline

30 Jun 2021

Submission Information

Articles of special issue are free of charge for article processing.
For Author Instructions, please refer to
For Online Submission, please login at
Submission Deadline: 30 Jun 2021
Contacts: Ryna Ni, Assistant Editor,

Published Articles

This special issue is now open for submission.
Copyright © 2021 OAE Publishing Inc. All Rights Reserved.